carmustine has been researched along with Waldenstrom Macroglobulinemia in 8 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Waldenstrom Macroglobulinemia: A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saini, NY | 1 |
| Patel, RD | 1 |
| Varma, A | 1 |
| Bashir, Q | 1 |
| Delgado, R | 1 |
| Rondon, G | 1 |
| Mukherjee, A | 1 |
| Popat, U | 1 |
| Hosing, C | 1 |
| Nieto, Y | 1 |
| Kebriaei, P | 1 |
| Weber, DM | 1 |
| Thomas, SK | 1 |
| Lee, HC | 1 |
| Manasanch, EE | 1 |
| Orlowski, RZ | 1 |
| Champlin, RE | 1 |
| Qazilbash, MH | 1 |
| Patel, KK | 1 |
| Marzolini, MA | 1 |
| Thomson, KJ | 1 |
| Dorman, J | 1 |
| D'Sa, S | 1 |
| Salmon, SE | 1 |
| Torrey, JJ | 1 |
| Katakkar, SB | 1 |
| Case, DC | 2 |
| Ervin, TJ | 1 |
| Boyd, MA | 1 |
| Redfield, DL | 1 |
| Cuttner, J | 1 |
| Lu, SF | 1 |
| Chen, XW | 1 |
| Lin, TB | 1 |
1 trial available for carmustine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Waldenström's macroglobulinemia: long-term results with the M-2 protocol.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dru | 1991 |
7 other studies available for carmustine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Su | 2019 |
BEAM-conditioned autologous SCT improves the quality of response in Waldenström's macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre's 10-year experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hu | 2014 |
In vitro cloning and chemosensitivity of human myeloma stem cells.
Topics: Animals; Carmustine; Cell Transformation, Neoplastic; Clone Cells; Colony-Forming Units Assay; DNA; | 1982 |
Treatable meningeal involvement in Waldenström's macroglobulinemia.
Topics: Aged; Carmustine; Central Nervous System Diseases; Drug Therapy, Combination; Female; Humans; Immuno | 1984 |
Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for Waldenström macroglobulinemia: preliminary report.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosph | 1982 |
Waldenström's macroglobulinemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; | 1991 |
[Diagnosis and treatment of Waldenstrom's macroglobulinemia: 4 case reports].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Diagnostic Errors; Fem | 1985 |